Corient Private Wealth’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
Corient Private Wealth's ELV Position: Q2 2026 in Review
Corient Private Wealth reduced its Elevance Health (ELV) stake by 41% in Q2 2026, selling an estimated $10.7M and leaving 41,278 shares worth $16M. The position accounts for 0.02% of the portfolio, ranked #493.
Corient Private Wealth first reported a position in ELV in Q4 2022 and has held it in 15 quarters since. The position peaked at $45.1M in Q2 2024. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Corient Private Wealth held 41,278 shares of Elevance Health worth $16M as of Q2 2026.
- Corient Private Wealth sold 28,940 Elevance Health shares in Q2 2026, an estimated $10.7M.
- Elevance Health made up 0.02% of Corient Private Wealth's portfolio in Q2 2026, its #493 holding.
- Corient Private Wealth first reported a position in Elevance Health in Q4 2022 and has held it in 15 quarters since.
- Corient Private Wealth's Elevance Health position peaked at $45.1M in Q2 2024.
- 1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.